minnelide / Minneamrita Therap 
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
minnelide / Minneamrita Therap
NCT05557851: Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas

Recruiting
1b
36
RoW
Minnelide
Minneamrita Therapeutics LLC
Metastatic Adenocarcinoma of the Pancreas
06/24
12/24
NCT03760523: Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia

Terminated
1
27
US
Minnelide
H. Lee Moffitt Cancer Center and Research Institute, Minneamrita Therapeutics LLC
Acute Myeloid Leukemia
10/23
10/23
Minnelide 101, NCT03129139: A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors

Recruiting
1
66
US
Minnelide™Capsules
Minneamrita Therapeutics LLC, Translational Drug Development
Advanced Cancer, Gastric Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer Metastatic, Colo-rectal Cancer, Solid Tumor, Solid Carcinoma, Solid Carcinoma of Stomach, Cancer of Stomach
06/24
12/24
NCT05566834: Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer

Recruiting
1
36
RoW
Minnelide
Minneamrita Therapeutics LLC
Gastric Cancer
06/24
11/24

Download Options